Everyone deserves equal access to medicines.

Cost is a key element limiting access to medicines in the United States and worldwide. We are determined to eliminate this problem through innovative technologies and by challenging the status quo.

Our first target is Insulin, a life-saving medication whose price has risen 500% in the last decade; we plan to manufacture insulin and provide it at the lowest possible price to patients in the US and in other countries.

Join us in our effort to restore some fairness to pharmaceutical access

6/23/2021 Senator Jacky Rosen introduced her “Expanding Access to Affordable Prescription Drugs and Medical Devices Act” a first-of-its-kind bill to directly address the high cost of drugs. See “News” for more detail

Our mission is to identify, develop, and deliver life-saving medicines to poorly-served patients in the US and worldwide at the lowest cost possible.

To achieve our vision, we look to attract grass roots support from individuals and organizations that share our view that access to medicines should be a right, not a privilege.

Our philosophy is that access to medications should not be limited by national borders, economic or political boundaries and that by harnessing the enormous power of modern drug development technologies, we can help to improve and enhance the quality of life and health in populations long ignored and exploited by the traditional Pharmaceutical and Healthcare industries.

We invite you to partner with us in achieving this goal. Because drug costs are a key element limiting access to medicines, we are determined to eliminate this problem by using innovative technologies and by challenging the status quo in drug supply.

In the News: "Renegades Join Forces for Affordable Insulin." Read the full story > — **In the News:** "Renegades Join Forces for Affordable Insulin." Read the full story >

“I work in the biotech business and have often thought about ways that we could/should give back. What you and your team is doing is truly inspiring and much needed.”

— Bay area Biotech Executive

“Patients should not have to choose between groceries or gas or their insulin. The working poor or the retired on marginal benefits—those with limited or no health insurance, with limited or no medication benefits, with no free clinic to get free meds—simply cannot afford to lower their blood sugar. ”

Daniel M. Becker, MD, M.P.H.; University of Virginia

President and Founder Jim Wilkins presents at Yale University.

Goals

Our goals align with our strong belief that access to medicines is a fundamental human right. Because of this, we have identified several target medicines that can be manufactured and supplied in a low-cost way. Our goal is to supply high quality medicines manufactured under FDA and EMA regulatory compliance at the lowest possible price.

View our initiatives >

History

We started Fair Access Medicines in response to the great disparity that exists between access to medicines in the prosperous "developed" world and the greatly limited access experienced by the vast majority of the rest of the world's population. The reason for this disparity lies at least in part, in the relentless pursuit of outsize profits by the worldwide pharmaceutical industry. We feel that there is an urgent need to balance this attitude by identifying opportunities to supply medicines at the lowest possible cost.